epirubicin has been researched along with Penile Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Köhn, FM; Meineke, V; Pickl, U; Ring, J; Vogt, HJ | 1 |
| Court, B; Culine, S; Droz, JP; Fadel, E; Haie-Meder, C; Kattan, J; Perrin, JL; Wibault, P | 1 |
2 other study(ies) available for epirubicin and Penile Neoplasms
| Article | Year |
|---|---|
[Malignant priapism as a sign of a recurrent prostate cancer. Differential diagnosis of induratio penis plastica].
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Diagnosis, Differential; Drug Therapy, Combination; Epirubicin; Estramustine; Flutamide; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Orchiectomy; Palliative Care; Penile Induration; Penile Neoplasms; Priapism; Prostatic Neoplasms; Time Factors | 2003 |
Penile cancer chemotherapy: twelve years' experience at Institut Gustave-Roussy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Doxorubicin; Epirubicin; Fluorouracil; Humans; Male; Methotrexate; Middle Aged; Penile Neoplasms; Survival Rate; Treatment Outcome; Vinblastine | 1993 |